These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Yoshikawa H; Watanabe T; Abe T Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104 [TBL] [Abstract][Full Text] [Related]
4. Effects of Sodium Valproate Combined with Lamotrigine on Quality of Life and Serum Inflammatory Factors in Patients with Poststroke Secondary Epilepsy. Tao S; Sun J; Hao F; Tang W; Li X; Guo D; Liu X J Stroke Cerebrovasc Dis; 2020 May; 29(5):104644. PubMed ID: 32081495 [TBL] [Abstract][Full Text] [Related]
6. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F; Igwe SC Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639 [TBL] [Abstract][Full Text] [Related]
7. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents. Grisotto KP; Bruck I; Antoniuk SA; Santos LH Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703 [TBL] [Abstract][Full Text] [Related]
10. Disabling tremor induced by long-term use of sodium valproate and lamotrigine: Case report. He ZF; Chen J; Zhou CN; Rao Z; Wang XH Medicine (Baltimore); 2017 Nov; 96(47):e8711. PubMed ID: 29381960 [TBL] [Abstract][Full Text] [Related]
11. Clinical and surface EMG characteristics of valproate induced tremors. Mehndiratta MM; Satyawani M; Gupta S; Khwaja GA Electromyogr Clin Neurophysiol; 2005; 45(3):177-82. PubMed ID: 15981690 [TBL] [Abstract][Full Text] [Related]
12. Distinguishing features between valproate-induced tremor and essential tremor. Alonso-Juarez M; Baizabal-Carvallo JF Acta Neurol Scand; 2018 Aug; 138(2):177-181. PubMed ID: 29749618 [TBL] [Abstract][Full Text] [Related]
13. Sodium valproate-related hyperammonaemic encephalopathy. Pegg EJ; Zaman F BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722719 [TBL] [Abstract][Full Text] [Related]
14. Stupor and fast activity on electroencephalography in a child treated with valproate. Mastrangelo M; Mariani R; Spalice A; Rocchi V; Iannetti P Pediatr Neurol; 2009 Jul; 41(1):53-6. PubMed ID: 19520277 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid and risperidone. Bertoldo M J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):632. PubMed ID: 12049437 [No Abstract] [Full Text] [Related]
16. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514 [TBL] [Abstract][Full Text] [Related]
17. Lesson of the month 1: Sodium valproate-induced encephalopathy. Camilleri L Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443 [TBL] [Abstract][Full Text] [Related]
18. [Cognitive impairment and parkinsonism due to use of sodium valproate]. Schreur L; Middeljans-Tijssen CW; Hengstman GJ; Olde Rikkert MG Tijdschr Gerontol Geriatr; 2009 Feb; 40(1):29-33. PubMed ID: 19326700 [TBL] [Abstract][Full Text] [Related]
19. The clinical features and functional impact of valproate-induced tremor. Alonso-Juarez M; Torres-Russotto D; Crespo-Morfin P; Baizabal-Carvallo JF Parkinsonism Relat Disord; 2017 Nov; 44():147-150. PubMed ID: 28941829 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of motor performance in epilepsy patients treated with valproate. Farkas Z; Gulyás S; Molnár R; Szirmai I; Kamondi A Seizure; 2010 Apr; 19(3):173-7. PubMed ID: 20167509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]